approval
saveOZURDEX (DEXAMETHASONE) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalDec 19, 2022 · 1385d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalOct 21, 2020 · 2174d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalMay 15, 2018 · 3064d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalFeb 5, 2016 · 3894d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalSep 26, 2014 · 4391d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalJun 28, 2014 · 4481d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalFeb 7, 2014 · 4622d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalSep 7, 2012 · 5140d ago
same company · ±60 days · 6
- approvalrisankizumab: SKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalMar 6, 2026
- approvalrisankizumab: SKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalMar 6, 2026
- approvalLumify: COMBIGAN (BRIMONIDINE TARTRATE) — FDA approvalMar 17, 2026
- approvalrisankizumab: SKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalMar 18, 2026
- approvalrisankizumab: SKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalMar 18, 2026
- approval(foscarbidopa + foslevodopa): VYALEV (FOSCARBIDOPA) — FDA approvalMar 19, 2026
comments(0)
5-min edit window · permanent after that